Product
Dipeptidyl peptidase-4 (DPP-4) inhibitors
1 clinical trial
6 indications
Indication
Type 2 DiabetesIndication
Heart AttackIndication
strokeIndication
Cardiovascular DeathIndication
Congestive Heart FailureIndication
MortalityClinical trial
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors and the Risk of Cardiovascular Events Among Patients With Type 2 Diabetes: a Multicenter Cohort StudyStatus: Completed, Estimated PCD: 2019-10-01